LIVECAST Markets Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Live News NEWS FLASH L impact Oct 06, 2026, 10:35 PM UTC

US Vice President Vance: undecided about presidential run - source interview

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

No ticker tags on this item.

Related stories

Surging Yields Hit Asian Bond Sales As AI Fundraising Trails US L impact | NEWS | Oct 06, 2026, 11:13 PM UTC * Fitch Assigns Expected Ratings to RedZed Trust Series 2026-3; Outlook Stable (MORE TO FOLLOW) Dow Jones Newswires October 06, 2026 19:12 ET (23:12 GMT) The statements in this document shall not be considered as an objective or independent explanation of the L impact | NEWS | Oct 06, 2026, 11:12 PM UTC Moody's Ratings Upgrades Rating On One Class Of Clo Notes Issued By Madison Park Funding Lxi, Ltd.; Action Concludes Review The following is a press release from Moody's: Moody's Ratings Upgrades Rating On One Class Of Clo Notes Issued By Madison Park Funding Lxi, Ltd.; Action Concludes Review (END) Dow L impact | NEWS | Oct 06, 2026, 11:12 PM UTC Surging Yields Hit Asian Bond Sales as AI Fundraising Trails US Borrowers in the Asia Pacific are slowing deals in the dollar bond market, with the highest yields in more than two years sapping deal momentum. L impact | NEWS | Oct 06, 2026, 11:12 PM UTC Japan Reuters Tankan Manufacturers Index Oct: +22 (prev +21) Non-Manufacturers Index Falls To +23 From +29 - January Manufacturers Index Seen At +23; Non-Manufacturers At +21 L impact | NEWS | Oct 06, 2026, 11:04 PM UTC Halozyme Therapeutics Expands Licensing Agreement With Argenx By Elias Schisgall Halozyme Therapeutics is expanding its partnership with Argenx, allowing the immunology company access to its Enhanze drug delivery technology with two additiona L impact | NEWS | Oct 06, 2026, 11:03 PM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.